HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

iron-magnesium hydroxycarbonate

a non-calcium-containing phosphate binder for the treatment of hyperphosphatemia in chronic hemodialysis patients

Also Known As:

fermagate

Networked: 1 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Hutchison, Alastair J: 1 article (02/2009)
2.	McIntyre, Christopher W: 1 article (02/2009)
3.	Pai, Pearl: 1 article (02/2009)
4.	Toft, Alex J: 1 article (02/2009)
5.	Warwick, Graham: 1 article (02/2009)
6.	Wilkie, Martin: 1 article (02/2009)

Related Diseases

1.

Hyperphosphatemia

02/01/2009 - "Fermagate showed promising efficacy in the treatment of hyperphosphatemia in chronic hemodialysis patients as compared with placebo in this initial phase II study. "
02/01/2009 - "This phase II study tested the safety and efficacy of fermagate, a calcium-free iron and magnesium hydroxycarbonate binder, for treating hyperphosphatemia in hemodialysis patients. "
02/01/2009 - "Iron-magnesium hydroxycarbonate (fermagate): a novel non-calcium-containing phosphate binder for the treatment of hyperphosphatemia in chronic hemodialysis patients."

Related Drugs and Biologics

1.	Iron
2.	Calcium
3.	magnesium hydroxycarbonate
4.	iron-magnesium hydroxycarbonate
5.	Phosphates (Orthophosphate)

Related Therapies and Procedures

1.	Renal Dialysis (Hemodialysis)